PODD

Insulet Corporation [PODD] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PODD Stock Summary

Top 10 Correlated ETFs

PODD

Top 10 Correlated Stocks

PODD

In the News

PODD Financial details

Company Rating
-
Market Cap
12.27B
Income
206.3M
Revenue
1.7B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
119.09
Forward P/E
-
PEG
0.27
P/S
9.18
P/B
23.52
P/C
-
P/FCF
-1143.39
Quick Ratio
2.12
Current Ratio
3.26
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.95
EPS next Y
-
EPS next Q
-
EPS this Y
4364.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
73.18%
Revenue last 5Y
18.12%
Revenue Q/Q
17.82%
EPS Q/Q
100%
-
-
-
-
SMA20
3.57%
SMA50
16.95%
SMA100
13.95%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
22%
ROC
0.05%
Gross Margin
65%
Oper. Margin
7%
Profit Margin
8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
125.82-335.91
52W High
-9.07%
52W Low
+143.7%
RSI
49.22
Rel Volume
0.72
Avg Volume
864.81K
Volume
621.06K
Perf Week
-4.57%
Perf Month
21.73%
Perf Quarter
18.79%
Perf Half Y
11.39%
-
-
-
-
Beta
1.003
-
-
Volatility
5.76%, 23.15%
Prev Close
0.33%
Price
304.63
Change
0.79%

Something similar

Top by Market Cap
BRYN.DE
MSFT
GOOGL
FXAIX
AMZN
Top Correlated ETFs
FLBL
XLYS.L
INFU.L
LONZ
SRLN
Top Correlated Stocks
TTD
0LF5.L
2484.TW
FROG
AERI.L
Similar Market Cap
2924.T
2120.T
7122.T
1235.TW
EXPE

Company Profile

Healthcare Medical - Devices
  • Volume Average 864.81K
  • Market Capitalization 12.27B
  • Employee 3K
  • CEO Dr. James R. Hollingshead Ph.D.
  • Headquarters Acton,MA,US
  • IPO Date 2007-05-15
  • Website https://www.insulet.com

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.